CREDIT SUISSE AG/ - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$202,693
-32.5%
134,234
+11.7%
0.00%
Q4 2022$300,508
-48.5%
120,203
-13.0%
0.00%
-100.0%
Q3 2022$583,000
+77.7%
138,217
+17.2%
0.00%
Q2 2022$328,000
-57.7%
117,886
-13.2%
0.00%
-100.0%
Q1 2022$776,000
-40.7%
135,833
-5.2%
0.00%0.0%
Q4 2021$1,308,000
+12.9%
143,262
+32.1%
0.00%0.0%
Q3 2021$1,159,000
-9.5%
108,416
+31.3%
0.00%0.0%
Q2 2021$1,281,000
+21.2%
82,587
+26.5%
0.00%0.0%
Q1 2021$1,057,000
-65.4%
65,271
-54.8%
0.00%0.0%
Q4 2020$3,057,000
+28.5%
144,369
-10.1%
0.00%0.0%
Q3 2020$2,379,000
+1.8%
160,563
+1.0%
0.00%
-50.0%
Q2 2020$2,338,000
+68.1%
158,935
+34.1%
0.00%
+100.0%
Q1 2020$1,391,000
-68.1%
118,495
-36.2%
0.00%
-66.7%
Q4 2019$4,364,000
+222.8%
185,676
+154.2%
0.00%
+200.0%
Q3 2019$1,352,000
+52.8%
73,042
+53.4%
0.00%0.0%
Q2 2019$885,000
-34.4%
47,609
-13.8%
0.00%0.0%
Q1 2019$1,350,000
-44.4%
55,235
-41.1%
0.00%
-66.7%
Q4 2018$2,430,000
+35.0%
93,705
+64.7%
0.00%
+50.0%
Q3 2018$1,800,000
-16.9%
56,903
+2.0%
0.00%0.0%
Q2 2018$2,166,000
+27.4%
55,782
-9.4%
0.00%0.0%
Q1 2018$1,700,000
+93.0%
61,593
+26.4%
0.00%
+100.0%
Q4 2017$881,000
-11.2%
48,724
-20.7%
0.00%0.0%
Q3 2017$992,000
-28.2%
61,423
-38.4%
0.00%0.0%
Q2 2017$1,382,000
-36.0%
99,744
-30.8%
0.00%
-50.0%
Q1 2017$2,161,000
+392.3%
144,061
+329.8%
0.00%
Q4 2016$439,000
-45.8%
33,522
-28.7%
0.00%
-100.0%
Q3 2016$810,000
-20.0%
47,040
-16.0%
0.00%0.0%
Q2 2016$1,012,000
-3.2%
56,002
+1.8%
0.00%0.0%
Q1 2016$1,045,000
+51.2%
55,020
+112.7%
0.00%0.0%
Q4 2015$691,000
+161.7%
25,869
+138.8%
0.00%
Q3 2015$264,000
-67.6%
10,834
-58.6%
0.00%
-100.0%
Q2 2015$815,000
+252.8%
26,185
+57.7%
0.00%
Q1 2014$231,00016,6000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TANG KEVIN 37,999$706,00024.13%
TANG CAPITAL MANAGEMENT LLC 5,744,096$106,783,00014.43%
BRIDGER MANAGEMENT, LLC 2,846,555$52,917,0004.15%
First Light Asset Management, LLC 1,098,723$20,425,0002.84%
Broadfin Capital, LLC 657,998$12,232,0002.66%
HIGHLAND CAPITAL MANAGEMENT LP 1,606,942$29,873,0001.75%
EMORY UNIVERSITY 129,020$2,398,0001.69%
Mesirow Financial Investment Management, Inc. 24,112$430,0001.57%
Congress Park Capital LLC 109,665$1,945,0001.54%
KINGDON CAPITAL MANAGEMENT, L.L.C. 830,821$15,445,0001.52%
View complete list of HERON THERAPEUTICS INC shareholders